SurgoCap Partners LP
About SurgoCap Partners LP’s 13F portfolio
SurgoCap Partners LP is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , SurgoCap Partners LP reported $3.1B across 13 US-listed positions (). Its largest position is TAIWAN SEMICONDUCTOR MANUFAC (TSM) at 14% of the reported book, and its ten biggest holdings make up 92% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.
| # | Stock | Price | % of portfolio | Shares | Value |
|---|---|---|---|---|---|
| 1 | NYSE: TSM TAIWAN SEMICONDUCTOR MANUFAC | $352.09 −2.90% | 14% | 908K | $433.7M |
| 2 | NYSE: CRS CARPENTER TECHNOLOGY CORP | $267.84 −1.41% | 14% | 686K | $423.4M |
| 3 | NASDAQ: GOOG ALPHABET INC | $271.02 −2.93% | 11% | 966K | $341.3M |
| 4 | NASDAQ: LPLA LPL FINL HLDGS INC | $270.33 −1.93% | 9.7% | 1.1M | $299.5M |
| 5 | NASDAQ: MDLN MEDLINE INC | $37.84 −3.37% | 9.5% | 7.5M | $295.3M |
| 6 | NYSE: MCK MCKESSON CORP | $1,062.16 −2.05% | 9.2% | 377K | $284.8M |
| 7 | NASDAQ: INTC INTEL CORP | $55.72 +1.92% | 8.3% | 1.8M | $258.1M |
| 8 | NYSE: GLW CORNING INC | $105.97 −2.02% | 6.6% | 797K | $203.6M |
| 9 | NYSE: V VISA INC | $402.25 −3.12% | 6.3% | 564K | $193.6M |
| 10 | NYSE: AGX ARGAN INC | $295.85 −2.67% | 3.9% | 150K | $119.8M |
| 11 | NYSE: NU NU HLDGS LTD | $11.82 −2.15% | 3.5% | 8.0M | $106.9M |
| 12 | NASDAQ: ISRG INTUITIVE SURGICAL INC | $407.24 −3.26% | 3.3% | 257K | $102.2M |
| 13 | NYSE: DPC DPC HOLDINGS PLC | — — | 1.0% | 639K | $31.3M |
Showing the 13 largest positions reported in this 13F.
- Technology29%
- Healthcare22%
- Financial Services19%
- Industrials18%
- Communication Services11%
- AddedLPLALPL FINL HLDGS INC+4.2%$299.5M
- AddedMDLNMEDLINE INC+23.2%$295.3M
- AddedMCKMCKESSON CORP+8.1%$284.8M
- NewINTCINTEL CORP—$258.1M
- AddedVVISA INC+95.7%$193.6M
- NewAGXARGAN INC—$119.8M
- NewDPCDPC HOLDINGS PLC—$31.3M
- ReducedTSMTAIWAN SEMICONDUCTOR MANUFAC−18.1%$433.7M
- ReducedCRSCARPENTER TECHNOLOGY CORP−42.6%$423.4M
- ReducedGOOGALPHABET INC−35.1%$341.3M
- ReducedGLWCORNING INC−7.1%$203.6M
- ReducedNUNU HLDGS LTD−18.9%$106.9M
- ReducedISRGINTUITIVE SURGICAL INC−22.8%$102.2M
- SoldNVDANVIDIA CORPORATION−100%—
- SoldFIGFIGMA INC−100%—
- SoldSHOPSHOPIFY INC−100%—
- SoldNIQNIQ GLOBAL INTELLIGENCE PLC−100%—
Reading SurgoCap Partners LP’s 13F portfolio
SurgoCap Partners LP’s $3.1B 13F book is spread across 13 reported positions and is highly concentrated — its ten largest positions alone are 92% of the portfolio. A book this concentrated means a small group of names drives most of its performance. Its five largest positions are TSM, CRS, GOOG, LPLA and MDLN, led by TAIWAN SEMICONDUCTOR MANUFAC (TSM) at 14% of the portfolio. The heaviest sector exposure is Technology (29%), then Healthcare (22%).
What SurgoCap Partners LP changed last quarter
Between 2026-03-31 and Q2 2026, SurgoCap Partners LP was a net seller: it opened 3 new positions and added to 4 more, while trimming 6 and closing 4 outright. Against a 13-name book, that is high turnover, pointing to an active reshuffle of the book. Its largest new or increased position was LPL FINL HLDGS INC (LPLA), and its biggest reduction was TAIWAN SEMICONDUCTOR MANUFAC (TSM).
What a 13F does and doesn’t reveal
A 13F captures only SurgoCap Partners LP’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names SurgoCap Partners LP is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.
Frequently asked questions
What is an SEC 13F filing?
A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. SurgoCap Partners LP's profile on this page is built directly from those filings.
How current is the 13F data on SurgoCap Partners LP's page?
It reflects SurgoCap Partners LP's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When SurgoCap Partners LP files its next quarterly report, this page refreshes automatically.
Can I see SurgoCap Partners LP's complete list of holdings?
This page highlights SurgoCap Partners LP's largest positions rather than all 13 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under SurgoCap Partners LP's filings.
Does a 13F show everything SurgoCap Partners LP owns?
No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of SurgoCap Partners LP's book rather than its full strategy or total assets.
Is 13F data investment advice?
No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why SurgoCap Partners LP made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.
Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.

